title: Knowledge-based approach to identify key determinants of cisplatin sensitivity .
authors.forename: Navin
authors.initials: N
authors.lastname: Sarin
authors.forename: Florian
authors.initials: F
authors.lastname: Engel
authors.forename: Ganna V
authors.initials: GV
authors.lastname: Kalayda
authors.forename: Roland
authors.initials: R
authors.lastname: Frötschl
authors.forename: Jindrich
authors.initials: J
authors.lastname: Cinatl
authors.forename: Florian
authors.initials: F
authors.lastname: Rothweiler
authors.forename: Martin
authors.initials: M
authors.lastname: Michaelis
authors.forename: Holger
authors.initials: H
authors.lastname: Fröhlich
authors.forename: Ulrich
authors.initials: U
authors.lastname: Jaehde
mesh_terms: D000072283:A549 Cells; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy*; D045744:Cell Line, Tumor; D002945:Cisplatin / Q000627:therapeutic use*; D006801:Humans; D015398:Signal Transduction / Q000187:drug effects / Q000235:genetics; D059467:Transcriptome / Q000187:drug effects / Q000235:genetics
chemical_list: D000970:Antineoplastic Agents; D002945:Cisplatin